GLN-METFORMIN XR DIN 02572273
Health Canada record
| Active ingredient(s) | METFORMIN HYDROCHLORIDE 1000 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BA02 METFORMIN |
| Original market date | |
| Current status date | 08-Oct-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Glenmark Pharmaceuticals Canada Inc. — licence 102261, currently licensed, last inspection rating C (2024-05-14).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METFORMIN HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02305062 | APO-METFORMIN ER | APOTEX INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02460653 | APO-METFORMIN ER | APOTEX INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02438283 | AURO-METFORMIN | AURO PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02438275 | AURO-METFORMIN | AURO PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02564262 | BIO-METFORMIN | BIOMED PHARMA | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02564270 | BIO-METFORMIN | BIOMED PHARMA | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Approved |
| 02099233 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02268493 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02300451 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02463601 | GPC-METFORMIN XR | STRIDES PHARMA CANADA INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02463628 | GPC-METFORMIN XR | STRIDES PHARMA CANADA INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Approved |
| 02380218 | JAMP METFORMIN | JAMP PHARMA CORPORATION | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02380196 | JAMP METFORMIN | JAMP PHARMA CORPORATION | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02403250 | JENTADUETO | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | METFORMIN HYDROCHLORIDE 500 MG; LINAGLIPTIN 2.5 MG | Marketed |
| 02378639 | MAR-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02378620 | MAR-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02550512 | MAR-METFORMIN XR | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02550504 | MAR-METFORMIN XR | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02378841 | METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02385368 | METFORMIN | SIVEM PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02353385 | METFORMIN | SANIS HEALTH INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02566907 | METFORMIN TABLETS | SANIS HEALTH INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02566915 | METFORMIN TABLETS | SANIS HEALTH INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Approved |
| 02565528 | METFORMIN XR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02567458 | METFORMIN XR | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02567431 | METFORMIN XR | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02388766 | MINT-METFORMIN | MINT PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02388774 | MINT-METFORMIN | MINT PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02547317 | MINT-METFORMIN XR | MINT PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02547309 | MINT-METFORMIN XR | MINT PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02448084 | NRA-METFORMIN TABLETS | NORA PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02378124 | PG-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Approved |
| 02378116 | PG-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02531909 | PRZ-METFORMIN | PHARMARIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02534673 | PRZ-METFORMIN | PHARMARIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02531895 | PRZ-METFORMIN | PHARMARIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02545675 | RIVA SITAGLIPTIN/METFORMIN | LABORATOIRE RIVA INC. | Tablet | METFORMIN HYDROCHLORIDE 1000 MG; SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Approved |
| 02570254 | RIVA-METFORMIN | LABORATOIRE RIVA INC. | Tablet | METFORMIN HYDROCHLORIDE 1000 MG | Approved |
| 02246820 | SANDOZ METFORMIN FC | SANDOZ CANADA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02246821 | SANDOZ METFORMIN FC | SANDOZ CANADA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02503964 | SANDOZ SITAGLIPTIN-METFORMIN | SANDOZ CANADA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) 50 MG | Marketed |
| 02552027 | TARO-METFORMIN XR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02565536 | TARO-METFORMIN XR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02257726 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02257734 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02406039 | ACH-METFORMIN | ACCORD HEALTHCARE INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02364514 | AVA-METFORMIN | AVANSTRA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02449331 | BIO-METFORMIN | BIOMED PHARMA | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02421836 | ECL-METFORMIN | ECL PHARMA GROUP LTD | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled (Unreturned Annual) |
| 02162849 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02380730 | JAMP-METFORMIN BLACKBERRY | JAMP PHARMA CORPORATION | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02380722 | JAMP-METFORMIN BLACKBERRY | JAMP PHARMA CORPORATION | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02361272 | NTP-METFORMIN | NT PHARMA CANADA LTD | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02520311 | PMSC-METFORMIN | PHARMASCIENCE INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Dormant |
| 02520303 | PMSC-METFORMIN | PHARMASCIENCE INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Dormant |
| 02449390 | PRIVA-METFORMIN | PHARMAPAR INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market |
| 02449404 | PRIVA-METFORMIN | PHARMAPAR INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02339110 | Q-METFORMIN | QD PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02379775 | SEPTA-METFORMIN | SEPTA PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Dormant |
| 02444941 | VAN-METFORMIN | VANC PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38452 | 2026-10-08 | Abbreviated New Drug Submission (ANDS) |
International API supply for METFORMIN HYDROCHLORIDE
25 valid EDQM Certificates of Suitability from 24 holders. 34 active FDA Drug Master Files.
Request a quote for GLN-METFORMIN XR